KarXT Matching Placebo clinical trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Adjunctive KarXT in Subjects with Inadequately Controlled Symptoms of Schizophrenia

This study is looking into a new medication called KarXT for adults with schizophrenia who aren't getting enough relief from their current treatments. It aims to see if KarXT can help reduce symptoms, compared to a dummy pill, over a 6-week period.